Tag Archives: IQT

Cardiac Safety – the industry perspective

Dr Boaz Mendzelevski, BioClinica Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     This year marks the 10th anniversary of the introduction of the ICH E14 guideline which was introduced to provide … Continue reading

Comments Off on Cardiac Safety – the industry perspective